80 likes | 80 Views
The United States Non-Invasive Prenatal Testing (NIPT) market is expected to touch a valuation of USD 2.5 Billion by 2028.
E N D
No. of Pages : 140 Geography Coverage : United States Price for Single User Licence : USD 2,500 Price for Global User Licence : USD 4,000 Delivery Time : Within 24 hours
“The United States Non-Invasive Prenatal Testing market is expected to touch a valuation of US$ 2.5 Bn by 2028”
The U.S. Non-Invasive Prenatal Testing market is growing with the increasing per capita income, growing interest, increase in incidences of chromosomal aneuploidies among fetus, development of advanced non-invasive prenatal testing products, rising awareness regarding non-invasive prenatal testing, rising focus on reimbursement for NIPT, increasing preference for non-invasive techniques over invasive methods and ACOG guidelines recommend NIPT for all pregnancies regardless of risk. The market shows high potential for growth in the future.
The Key Market Players for the U.S Non-Invasive Prenatal Testing Market are Listed Below: Illumina Natera Quest Diagnostics Myriad Genetics Centogene GenPath Progenity PerkinElmer
Key Market Players Continued • Yourgene Health • Invitae Corporation • Agilent Technologies • Ariosa Diagnostics (Roche) • Integrated Genetics (LabCorp)
About DPI Research DPI Research is a leading market research publisher that offers bespoke market research reports, custom research and consulting services across multi geographies and industry verticals. To cater to the customers’ needs, DPI Research customizes the research data to each business inquiry and creates first-class reports that contain unique analytical findings and solutions.
Maria Rai Manager Tel: +91.7667648693 sales@dpiresearch.com www.dpiresearch.com For More Details https://dpiresearch.com/ Contact US